Company Profile
Genesis Molecular AI
Headquarters
Burlingame, California, USA
Year Founded
2019
Top Impacted Industries
Pharmaceuticals, Biotechnology, Drug Discovery, Life Sciences, Healthcare
About Us
Genesis Molecular AI (formerly Genesis Therapeutics) develops AI technology for small-molecule drug discovery. Its GEMS platform combines foundation models, generative AI, molecular simulation, and computational chemistry to generate drug candidates, predict molecular properties, evaluate protein-ligand interactions, and guide lead optimization.
Related Articles
Trending Companies
Latest Articles
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2026 All Rights Reserved.